MF59: A safe and potent oil in water emulsion adjuvant for influenza vaccines, which induces enhanced protection against virus challenge
Authors:
- 1 January 2008
- book chapter
- Published by Springer Nature
- p. 221-244
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Vaccines with the MF59 Adjuvant Do Not Stimulate Antibody Responses against SqualeneClinical and Vaccine Immunology, 2006
- A universal vaccine for serogroup B meningococcusProceedings of the National Academy of Sciences, 2006
- Anticipating crisis: Towards a pandemic flu vaccination strategy through alignment of public health and industrial policyVaccine, 2005
- Cross‐Reactivity to Highly Pathogenic Avian Influenza H5N1 Viruses after Vaccination with Nonadjuvanted and MF59‐Adjuvanted Influenza A/Duck/Singapore/97 (H5N3) Vaccine: A Potential Priming StrategyThe Journal of Infectious Diseases, 2005
- Use of CpG oligodeoxynucleotides as immunoprotective agentsExpert Opinion on Biological Therapy, 2004
- Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosisEuropean Journal of Immunology, 2001
- Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenzaThe Lancet, 2001
- MF59 Adjuvant Enhances the Antibody Response to Recombinant Hepatitis B Surface Antigen Vaccine in PrimatesThe Journal of Infectious Diseases, 1996
- Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59Vaccine, 1995
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974